Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2021 | Seed | £6M | 1 | Oxford Science Enterprises | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Oxford Science Enterprises | Yes | Seed |